Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iressa in pretreated EGFR wild-type advanced NSCLC
NCT01312337Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Sep 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01312337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01312337.